The role of cortisol, C-reactive protein and brain-derived neurotrophic factor in predicting anxiety, depression and mood swings: a cross-sectional study
DOI:
https://doi.org/10.55629/pakjpathol.v36i2.906Abstract
Objective: To evaluate the role of serum biomarkers—Cortisol, C-reactive protein (CRP), and brain-derived neurotrophic factor (BDNF)—to predict severity of mental health conditions like anxiety, depression, and mood disturbances.
Material and Methods: A cross-sectional study was conducted at Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, from February 2024 to September 2024, involving 283 participants. Mental health symptoms were assessed using standardized scales, including the Generalized Anxiety Disorder-7 (GAD-7) for anxiety, the Patient Health Questionnaire-9 (PHQ-9) for depression, the Mood Disorder Questionnaire (MDQ) for mood swings, and the Perceived Stress Scale (PSS) for stress evaluation. Biomarker analysis involved measuring salivary cortisol levels (morning, afternoon, and evening samples) and serum concentrations of C-reactive protein (CRP) and brain-derived neurotrophic factor (BDNF). Data were analyzed using Pearson’s correlation and one-way ANOVA with Tukey’s post hoc comparisons.
Results: Morning cortisol levels were significantly associated with anxiety (p < 0.001), while CRP exhibited a strong correlation with depression severity (r = 0.85, p < 0.001). Participants with severe mood swings had significantly lower BDNF levels compared to those with mild or moderate symptoms (p < 0.01). No significant correlations were found between afternoon or evening cortisol and anxiety or between BDNF and depression.
Conclusion: The findings suggest that elevated morning cortisol, high CRP, and low BDNF are potential biomarkers for predicting anxiety, depression, and mood swings, respectively. These biomarkers could aid in mental health diagnostics and personalized treatment approaches.
Keywords: Cortisol, C-reactive protein (CRP), Brain-derived neurotrophic factor (BDNF), anxiety, Depression, Mood swings, Biomarkers, Mental health
References
Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009; 72(1): 67-73. DOI:https://doi.org/10.1016/j.ijpsycho.2008.03.014
Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels. Psychol Med. 2019; 51(12): 1958–71. DOI: https://doi.org/10.1017/S0033291719001454
Wang Y, Liu Y, Wang D, Li X, Gao H, Jin Q, et al. Association between C-reactive protein and severity of depressive symptoms in major depressive disorder: A dose-response meta-analysis. Front Psychiatry. 2022; 15:1339208. DOI: https://doi.org/10.3389/fpsyt.2024.1339208
Köhler-Forsberg O, Buttenschøn HN, Tansey KE, Maier W, Hauser J, et al. Association between CRP with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017; 98: 349–58. DOI: https://doi.org/10.1016/j.bbi.2017.02.020
Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Acta Psychiatr Scand. 2017; 144(1): 5–19. DOI: https://doi.org/10.1111/acps.12698
Miller AH, Haroon E, Felger JC. The immunology of behavior— Exploring the Role of the Immune System in Brain Health and Illness. Neuropsychopharmacology. 2016; 42(01): 1-4. DOI: https://doi.org/10.1038/npp.2016.229
Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull. 2014; 148(3): 268–87. DOI: https://doi.org/10.1037/a0035302
Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, TNF-α, and CRP in major depressive disorder. Brain Behav Immun. 2015; 91: 206-15. DOI: https://doi.org/10.1016/j.bbi.2015.06.001
Zalli A, Jovanova O, Hoogendijk WJG, Tiemeier H, Carvalho LA. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016; 238(4): 1219–30. DOI: https://doi.org/10.1007/s00213-015-3919-9
Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007; 100: 153-60. DOI: https://doi.org/10.1016/j.bbi.2006.09.006
Harrison NA, Cercignani M, Blakemore SJ, Vuilleumier P. Brain functional and structural changes in inflammation: A systematic review and meta-analysis. Brain Behav Immun. 2018; 102: 76-92. DOI: https://doi.org/10.1016/j.neubiorev.2018.07.013
Capuron L, Miller AH. Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol Ther. 2022; 175: 129–47. DOI:https://doi.org/10.1016/j.pharmthera.2011.01.014
Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection. Brain Behav Immun. 2022; 26(2): 245–51. DOI: https://doi.org/10.1016/j.bbi.2009.12.009
Felger JC, Treadway MT. Inflammation effects on motivation and motor activity: Role of dopamine. Neuropsychopharmacology. 2017; 46(1): 155–62. DOI: https://doi.org/10.1038/npp.2016.143
Lee B-H, Kim Y-K. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig. 2010; 7(4): 231-5. DOI: https://doi.org/10.4306/pi.2010.7.4.231
Dean OM, Kanchanatawan B, Ashton MM, Mohebbi M, Ng CH, Berk M, et al. Peripheral biomarkers and antidepressant response: A systematic review. J Affect Disord. 2018; 233: 3-14. DOI: https://doi.org/10.1016/j.jad.2017.07.001
Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsych-opharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012; 37(1): 137–62. DOI: https://doi.org/10.1038/npp.2011.205
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci. 2021; 22(1): 45–61. DOI: https://doi.org/10.1038/nrn2297
Lopresti AL, Drummond PD. Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 113: 110470. DOI: https://doi.org/10.1016/j.pnpbp.2013.05.005
Leonard BE, Wegener G. Inflammation, insulin resistance, and neuroprogression in depression. Acta Neuropsychiatr. 2022; 34(1): 4–16. DOI: https://doi.org/10.1017/neu.2019.17
Capuron L, Pagnoni G, Demetrashvili MF, Woolwine BJ, Nemeroff CB, et al. Anterior cingulate activation during interferon-alpha administration. Biol Psychiatry. 2005; 58(3): 190-6. DOI: https://doi.org/10.1016/j.biopsych.2005.03.033
Rahman R, Sheehan D, Javed A, Ahmad SH, Shafiq K, Kanwal U, et al. The National Psychiatric Morbidity Survey of Pakistan. medRxiv. 2022. DOI: https://doi.org/10.1101/2024.07.08.24310056
Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: Implications for health. Nat Rev Immunol. 2005; 5(3): 243–51. DOI: https://doi.org/10.1038/nri1571
Miller AH, Raison CL. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016; 16(1): 22–34. DOI: https://doi.org/10.1038/nri.2015.5
Howren MB, Lamkin DM, Suls J. Associations of depression with CRP, IL-1, and IL-6: A meta-analysis. Psychosom Med. 2021;71(2):171–186. DOI: https://doi.org/10.1097/psy.0b013e3181907c1b
Slavich GM, Cole SW. The emerging field of human social genomics. Clin Psychol Sci. 2021; 1(3): 331–48. DOI: https://doi.org/10.1177/2167702613478594
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Editor Office
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
